Literature DB >> 15918208

An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report.

Chiara Fulignati1, Pietro Pantaleo, Greta Cipriani, Marianna Turrini, Rosalia Nicastro, Roberto Mazzanti, Bruno Neri.   

Abstract

We report the case of a patient affected by an extra-nodal non-Hodgkin lymphoma presenting as a unique, large retroperitoneal mass with an unusual clinical presentation mimicking gastric peptic or neoplastic disease. The patient was successfully treated with a first generation therapy, CHOP modified regimen (cyclophosphamide 600 mg/m2 intravenously on d 1, epirubicin 55 mg/m2 intravenously on d 1, vincristine 1.2 mg/m2 intravenously on d 1, prednisone 60 mg/m2 on d 1-5), and a complete response was achieved. The (18)F-fluorodeoxyglucose positron emission tomography was used to assess the therapy outcome. A brief review of literature is provided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918208      PMCID: PMC4305858          DOI: 10.3748/wjg.v11.i20.3151

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

2.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

Review 3.  Indolent lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; P L Zinzani; P Went; A Pileri; M Bendandi
Journal:  Ann Oncol       Date:  2004-01       Impact factor: 32.976

Review 4.  Post-treatment surveillance of patients with lymphoma treated with curative intent.

Authors:  James E Wooldridge; Brian K Link
Journal:  Semin Oncol       Date:  2003-06       Impact factor: 4.929

5.  Retroperitoneal mass presentations of B-immunoblastic sarcoma.

Authors:  J A Waldron; M Magnifico; P H Duray; E C Cadman
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

Review 6.  Current treatment options in aggressive lymphoma.

Authors:  Robert Marcus
Journal:  Leuk Lymphoma       Date:  2003

7.  Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma.

Authors:  Bart Schot; Gustaaf van Imhoff; Jan Pruim; Wim Sluiter; Willem Vaalburg; Edo Vellenga
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

Review 8.  Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.

Authors:  Bertrand Coiffier
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

Review 9.  New treatment approaches to indolent non-Hodgkin's lymphoma.

Authors:  John F Seymour
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

10.  [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.

Authors:  F Montravers; D McNamara; J Landman-Parker; D Grahek; K Kerrou; N Younsi; M Wioland; G Leverger; J N Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-25       Impact factor: 9.236

View more
  3 in total

1.  Non-Hodgkin's lymphoma with uncommon clinical manifestations: A case report.

Authors:  Yu-Long Cai; Xian-Ze Xiong; Jiong Lu; Yi-Xin Lin; Nan-Sheng Cheng
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

2.  Concurrent Incidental Presentation of Primary Retroperitoneal Follicular Lymphoma With Acute Pancreatitis.

Authors:  Dominic Gaziano; Aelia Akbar; Komal Lakhani; Toochukwu L Okafor; Siddharth Bhesania
Journal:  Cureus       Date:  2020-11-24

3.  A rare reason of abdominal compartment syndrome: non-Hodgkin lymphoma.

Authors:  Mehmet Abdussamet Bozkurt; Kaplan Baha Temizgönül; Osman Köneş; Halil Alış
Journal:  J Korean Surg Soc       Date:  2012-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.